186 related articles for article (PubMed ID: 23197999)
1. Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines.
Ling GQ; Chen DB; Wang BQ; Zhang LS
Oncol Lett; 2012 Dec; 4(6):1264-1268. PubMed ID: 23197999
[TBL] [Abstract][Full Text] [Related]
2. The role of Nanog expression in tamoxifen-resistant breast cancer cells.
Arif K; Hussain I; Rea C; El-Sheemy M
Onco Targets Ther; 2015; 8():1327-34. PubMed ID: 26082649
[TBL] [Abstract][Full Text] [Related]
3. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.
Chang MC; Vargas SO; Hornick JL; Hirsch MS; Crum CP; Nucci MR
Int J Gynecol Pathol; 2009 Jul; 28(4):347-55. PubMed ID: 19483629
[TBL] [Abstract][Full Text] [Related]
4. Expression and role of Oct3/4, Nanog and Sox2 in regeneration of rat tracheal epithelium.
Song N; Jia XS; Jia LL; Ma XB; Li F; Wang EH; Li X
Cell Prolif; 2010 Feb; 43(1):49-55. PubMed ID: 19845688
[TBL] [Abstract][Full Text] [Related]
5. Changes in the methylation status of the Oct3/4, Nanog, and Sox2 promoters in stem cells during regeneration of rat tracheal epithelium after injury.
Zhou Y; Song N; Li X; Han Y; Ren Z; Xu JX; Han YC; Li F; Jia X
Oncotarget; 2017 Jan; 8(2):2984-2994. PubMed ID: 27935870
[TBL] [Abstract][Full Text] [Related]
6. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.
Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H
Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932
[TBL] [Abstract][Full Text] [Related]
7. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma.
Matsuoka J; Yashiro M; Sakurai K; Kubo N; Tanaka H; Muguruma K; Sawada T; Ohira M; Hirakawa K
J Surg Res; 2012 May; 174(1):130-5. PubMed ID: 21227461
[TBL] [Abstract][Full Text] [Related]
8. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
[TBL] [Abstract][Full Text] [Related]
9. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
10. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic dsRNA induces the expression of
Wang G; Kouwaki T; Mugikura K; Okamoto M; Takaki H; Funami K; Seya T; Oshiumi H
J Biol Chem; 2019 Dec; 294(50):18969-18979. PubMed ID: 31615841
[TBL] [Abstract][Full Text] [Related]
12. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
[TBL] [Abstract][Full Text] [Related]
13. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.
Bae KM; Su Z; Frye C; McClellan S; Allan RW; Andrejewski JT; Kelley V; Jorgensen M; Steindler DA; Vieweg J; Siemann DW
J Urol; 2010 May; 183(5):2045-53. PubMed ID: 20303530
[TBL] [Abstract][Full Text] [Related]
14. Identification of pluripotent cells in bovine uterus: in situ and in vitro studies.
Łupicka M; Bodek G; Shpigel N; Elnekave E; Korzekwa AJ
Reproduction; 2015 Apr; 149(4):317-27. PubMed ID: 25556182
[TBL] [Abstract][Full Text] [Related]
15. Characterization of stem cell attributes in human osteosarcoma cell lines.
Wang L; Park P; Lin CY
Cancer Biol Ther; 2009 Mar; 8(6):543-52. PubMed ID: 19242128
[TBL] [Abstract][Full Text] [Related]
16. Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells.
Tomizawa M; Shinozaki F; Motoyoshi Y; Sugiyama T; Yamamoto S; Ishige N
Oncol Lett; 2018 Oct; 16(4):5243-5248. PubMed ID: 30250594
[TBL] [Abstract][Full Text] [Related]
17. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of Oct3/4 in human breast cancer and normal tissues.
Zhao FQ; Misra Y; Li DB; Wadsworth MP; Krag D; Weaver D; Tessitore J; Li DW; Zhang G; Tian Q; Buss K
Int J Oncol; 2018 Jun; 52(6):2069-2078. PubMed ID: 29620155
[TBL] [Abstract][Full Text] [Related]
19. Human embryonic and neuronal stem cell markers in retinoblastoma.
Seigel GM; Hackam AS; Ganguly A; Mandell LM; Gonzalez-Fernandez F
Mol Vis; 2007 Jun; 13():823-32. PubMed ID: 17615543
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gene-specific DNA methylation patterns in equine induced pluripotent stem cell lines with cells derived from equine adult and fetal tissues.
Hackett CH; Greve L; Novakofski KD; Fortier LA
Stem Cells Dev; 2012 Jul; 21(10):1803-11. PubMed ID: 21988203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
